- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
LFMD
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
LifeMD Inc · Healthcare · Health Information Services
Latest close
3.50 USD
-5.7%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -11.1% below the Trend Line and sits at 9.3% of its 52-week range. The latest completed week returned -5.7%, after a -28.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 36/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.
Setup score
18
out of 100
Latest Close
3.50 USD
31 Jul 2026
1W Return
-5.7%
latest completed week
4W Return
-28.1%
short-term follow-through
12W Return
-26.8%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-5.7%
Latest completed week; four-week move -28.1%.
Indicator stack
11/33
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.31%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Bullish
36/100 conviction; expected move 25.0%.
News sentiment
54/100
49 relevant articles in the latest sentiment read.
Event risk
2d
Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -11.1% below the Trend Line and sits at 9.3% of its 52-week range. The latest completed week returned -5.7%, after a -28.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3412-week average 0.28
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.34Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -28.1% over four weeks, -26.8% over 12 weeks, and -64.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.34Latest activity-pressure read.
Pressure change-135.7%Four-week change in activity pressure.
Leadership-29.45Latest relative-leadership reading.
RS change-72.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 85%
Model confidence 81%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value26/100Relative valuation strength. Underlying universe rank 75; rank 1 is best.
Quality70/100Profitability and accounting quality. Underlying universe rank 31; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth20/100Revenue and earnings growth. Underlying universe rank 81; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 0.8x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 10.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 85.9% Gross profit retained from each unit of revenue.
- Operating margin
- -6.4% Operating profit retained from revenue.
- Free-cash-flow margin
- 7.0% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -6.2% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -44.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.7% Cash dividends relative to market value.
- Buyback yield
- -4.9% Net share repurchases relative to market value.
- Shareholder yield
- -3.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 6.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningBullish
LFMD shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.36, expected move of 25.0%, and Sharemaestro trend signal inactive.
Conviction36/100
Expected move25.0%
Put/call volume0.36
Insider activity2 / 0
2 acquisitions and 0 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment54/100
Weighted news tone is neutral across 49 relevant articles.
14 positive · 30 neutral · 5 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move25.0%Nearest-chain priced movement where available.
52-week drawdown-72.5%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher10 of 2616 weeks finished lower.
Best week+32.7%Week of 13 Mar.
Worst week-13.1%Week of 26 Jun.
Latest week-5.7%Week of 31 Jul.
Shape of recent returns
Strong gains7
Modest gains3
Flat weeks0
Modest losses5
Sharp losses11
Recent vol9.0%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split16/36Count of positive and negative weeks in the 52-week window.
Average skew10.2% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average-1.5%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD78.0%positive activity pressure
RS49.0%positive relative leadership
Four-week leaders
IndustryUS Health Information Services
4-week rank38 / 42
Group average-5.1%
Trend breadth45.2%
Trend45.2%active weekly trend signals
MD78.6%positive activity pressure
RS28.6%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape20/100
Trend, activity pressure, participation, and risk combine to a 20/100 tape read.
Indicator analysis53/100Latest 12-week confirmation: trend 9/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.34; No reversal markers Next-Week ExpectancyNegative 42.31%Next-week expectancy is negative with a 42.31% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors28/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 83; Buyback Yield rank 82; Small Cap Core rank 84 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Options42/100LFMD shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.36, expected move of 25.0%, and Sharemaestro trend signal inactive.
Bullish · Call-side pressure · Expected move 25.0% Sentiment54/100Weighted news tone is neutral across 49 relevant articles.
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis Insiders2 / 02 acquisitions and 0 disposals in the latest 180-day insider tape.
Earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 3.50 USD | -5.7% | 3.94 USD | 6.24 USD | -0.34 | -29.45 | 3.9M | Off |
| 24 Jul 2026 | 3.71 USD | -10.6% | 3.94 USD | 6.24 USD | 0.18 | -27.32 | 4.4M | On |
| 17 Jul 2026 | 4.15 USD | -10.6% | 3.93 USD | 6.25 USD | 0.46 | -22.69 | 2.6M | On |
| 10 Jul 2026 | 4.64 USD | -4.7% | 3.90 USD | 6.25 USD | 0.76 | -19.73 | 3.4M | On |
| 3 Jul 2026 | 4.87 USD | 17.9% | 3.86 USD | 6.24 USD | 0.96 | -17.03 | 6.4M | On |
| 26 Jun 2026 | 4.13 USD | -13.1% | 3.81 USD | 6.24 USD | 1.04 | -31.55 | 5.4M | On |
| 19 Jun 2026 | 4.75 USD | 1.1% | 3.80 USD | 6.24 USD | 1.17 | -27.95 | 4.2M | On |
| 12 Jun 2026 | 4.70 USD | -3.9% | 3.77 USD | 6.24 USD | 1.20 | -30.08 | 4.2M | On |
| 5 Jun 2026 | 4.89 USD | 14.3% | 3.77 USD | 6.23 USD | 1.20 | -28.13 | 4.6M | On |
| 29 May 2026 | 4.28 USD | 2.1% | 3.78 USD | 6.21 USD | 1.22 | -41.91 | 3.5M | On |
| 22 May 2026 | 4.19 USD | -3.2% | 3.83 USD | 6.20 USD | 1.35 | -43.43 | 4.0M | Off |
| 15 May 2026 | 4.33 USD | -9.4% | 3.91 USD | 6.19 USD | 1.53 | -42.63 | 5.1M | Off |
| 8 May 2026 | 4.78 USD | -4.4% | 3.96 USD | 6.17 USD | 1.54 | -38.49 | 6.5M | Off |
| 1 May 2026 | 5.00 USD | 7.8% | 4.01 USD | 6.15 USD | 1.32 | -33.33 | 4.2M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.